Schedule 13G ownership disclosure
Contineum Therapeutics Inc
Class A Common Stock, $0.001 par value per share · CUSIP: 21217B100
Event date: 2025-07-18
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- RA Capital Management, L.P.
Shares: 2,122,000.00 · Class: 9.9%
- Peter Kolchinsky
Shares: 2,122,000.00 · Class: 9.9%
- Rajeev Shah
Shares: 2,122,000.00 · Class: 9.9%
- RA Capital Healthcare Fund, L.P.
Shares: 2,122,000.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-020291
- Form type
- SCHEDULE 13G
- Filer
- Contineum Therapeutics, Inc.
- CIK
- CIK 1855175
- Filed
- Jul 25, 2025
- Reporting period
- Jul 18, 2025
- Description
- Schedule 13G beneficial ownership